The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy.
Nicola A ThompsonGrant D StewartSarah J WelshGary J DohertyMatthew J RobinsonB Anne NevilleKevin VervierSimon R HarrisDavid J AdamsKaty DalchauDavid BruceNikolaos DemirisTrevor D LawleyPhilippa CorriePublished in: BMC cancer (2022)
NCT04107168 , ClinicalTrials.gov, registered 09/27/2019. Protocol V3.2 (16/04/2021).